SCHEDULE 13G/A

Context Therapeutics, Inc.

Common Stock, $0.001 par value per share · CUSIP: 21077P108

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Deep Track Capital, LP

  Shares: 7,419,355.00 · Class: 8.27%

• Deep Track Biotechnology Master Fund, Ltd.

  Shares: 7,419,355.00 · Class: 8.27%

• David Kroin

  Shares: 7,419,355.00 · Class: 8.27%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.